Medtronic (MDT) revenue and earnings history
Medtronic reported revenue of $36.4B for fiscal 2026 (year ended Apr 24, 2026), +8.4% on the year before, and net income of $4.8B.
Over 13 years, from fiscal 2013 to fiscal 2026, revenue grew at a compound rate of +6.2% a year.
Revenue and net income, 14 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Apr 24, 2026 | $36.4B+8.4% | $6.47B | $4.8B | $7.33B | $1.9B | $5.43B | $457M | $1.03B | $3.64B | $1.95B | $28B | 10-K |
| 2025 |
The latest quarter, insider trades and fund moves: Medtronic (MDT) on OQRO.
Common questions
What was Medtronic's revenue in fiscal 2026?
$36.4B for the year ended Apr 24, 2026, as reported in its 10-K filed Jun 18, 2026. That is +8.4% on fiscal 2025 ($33.5B).
How fast has Medtronic's revenue grown?
From $16.6B in fiscal 2013 to $36.4B in fiscal 2026: a compound annual growth rate of +6.2% over 13 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Medtronic tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
